Atlas Platform

Differentiate your clinical research with precision measures

HumanFirst’s AI-powered insights and evidence platform – with validated digital health technologies, digital biomarkers, eCOAs, research partners & educational tools – helps biopharma bring better treatments to market faster

Request Demo

Unlock precision measures for your research with HumanFirst

Research teams work with HumanFirst to:

Put Patients First

What precision measures matter to patients? Can we use these to differentiate our portfolio and bring better, patient-centered treatments to market faster?

Develop Novel Protocols

What assessments, including COAs and non-digital biomarkers, should we include in our protocol to make clinical research more effective?

Increase R&D Efficiency

How can we eliminate the risk of poor measurement selection or incomplete data to bring treatments to market faster and improve the lives of patients?

Our evidence at a glance

18,000+

Measures

Physiological and behavioral measures classified into 850+ categories

3,600+

Technologies

The most robust precision measures platform on the market is growing daily

1,300+

Medical Conditions

Clinical areas spanning 20+ therapeutic areas

15,000+

Pieces of Evidence

Clinical trials, peer-reviewed papers, conference abstracts, FDA decisions, and more!

Why validated precision measures?

Differentiate your assets

Unlock novel measures, new clinical endpoints and target patient populations to maximize return on research investment.

Improve research diversity and inclusivity

Increase geographic, racial, age, and socioeconomic inclusivity by eliminating accessibility burdens for research participants.

“PubMed is daunting – I either don’t find anything or find too much to sift through. Atlas gives me the information I need to confidently make a good decision, quickly.”

Digital Health Scientist, Top 5 Pharmaceutical Company

Be First with HumanFirst

HumanFirst’s AI-powered insights and evidence platform accelerates and precisely guides biopharma’s drug development and health strategy outcomes

Digital biomarkers & eCOAs

We harness the evidence of AI-powered digital biomarkers and eCOAs to help biopharma accelerate patient-centered clinical research

Validated Evidence

All evidence in our platform meets predefined quality metrics. For example:

Peer-reviewed papers must include the make and model of a specific product

Regulatory decisions are focused on FDA 510(k) and De Novo clearances

Clinical trials are focused on industry-sponsored trials

We work with many collaborators to update our evidence, including but not limited to:

Clinical Trial Transformation Initiative
via the Feasibility Studies Database

Scripps Research Translational Institute
via the Digital Health Library (Press Release)

Harvard-MIT Center for Regulatory Science
this Nature npj paper uses Atlas data!

The Platform

The platform enables more efficient, evidence based decisions on measures and tools and greater confidence in downstream use in a study or care management

Request Demo

The API

BETA

Choose our API for custom solutions and the ability to ingest metadata on 3,000+ technologies and 15,000+ measures across 1,000+ medical conditions directly

Learn more